Welcome to #1 DIGITAL HEALTH NEWS Portal

Building a 3D Brain Atlas

Texas Biomed will help map the developing brain with unprecedented detail for the National Institutes of Health’s BRAIN Initiative Cell Atlas Network (BICAN). NIH recently awarded a total of $500 million to 11 teams that will work together to build a 3D brain atlas at single cell resolution over the next five years.

Read more ...

€9 Million to Develop Europe's AI-on-Demand Platform

The European Commission has financed a consortium to develop the next phase of Europe's strategically important artificial intelligence (AI) infrastructure known as the AI-on-demand (AIOD) platform.

Through the Horizon Europe Programme (Artificial Intelligence and Robotics), the AI4Europe project, led by Irish University College Cork (UCC) has been awarded €9 million to develop the platform.

Read more ...

University of Tübingen and Boehringer Ingelheim Join Forces to Lead AI and Data Science R&D for New Medical Breakthroughs

University of Tübingen, a leading member of Cyber Valley, Europe's largest Artificial Intelligence (AI) research consortium and Boehringer Ingelheim launch an AI and data science fellowship program for top talents from around the world. Three to five fellowships will be awarded per year for up to three years with a target of nine to fifteen fellows in the program after five years.

Read more ...

Telemedicine Reduces Odds of No-Show Clinic Visits by More than Two-Thirds for Surgical Patients

Surgical patients who use telehealth services are much more likely to show up for their initial clinic visit or follow-up appointment during the post-surgery period than those who rely on in-person visits only. Research findings were presented at the Scientific Forum of the American College of Surgeons (ACS) Clinical Congress 2022.

Read more ...

Orion Health Appoints New Global Chief Executive

Shared care record and population health management provider Orion Health has a new chief executive. Brad Porter will lead the transition to a new phase for the business after 30 years of Ian McCrae at the helm.

Speaking during his first visit to the United Kingdom in his new role, Porter said: "The UK has always been an important market for Orion Health globally and we remain committed to our UK partners and customers."

Read more ...

Can Smartphones Predict Mortality Risk?

Passive smartphone monitoring of people’s walking activity can be used to construct population-level models of health and mortality risk, according to a new study publishing October 20th in the open access journal PLOS Digital Health by Bruce Schatz of University of Illinois at Urbana-Champaign, USA, and colleagues.

Read more ...

ki:elements Publishes New Validation Results on Remote Speech Biomarker for Cognition (SB-C) in Early Alzheimer's Disease

Digital speech biomarker company ki:elements has published validation results on the use of its ki:e speech biomarker for cognition (SB-C) in early Alzheimer’s disease in the "Karger - Digital Biomarkers" journal.(1)

Two European dementia studies - the Dutch DeepSpA study in collaboration with Maastricht University & the Scottish SPeAK study in collaboration with University of Edinburgh - helped to validate the psychometric properties of the SB-C.

Read more ...

Crisis, What Crisis? When Things Go Wrong, Good Communications can Get You Back on Track

Opinion Article by Mark Venables, Co-Founder, Highland Marketing.
The thing with crises is that they're sudden, unexpected, and not under your control. You think it'll never happen to you, then you're part of the news cycle - and not in a good way.

In our sector, problems are pretty much inevitable. Think about it. Healthcare technology is tricky stuff.

Read more ...

Cleveland Clinic and IBM Begin Installation of IBM Quantum System One

Cleveland Clinic and IBM have begun deployment of the first private sector onsite, IBM-managed quantum computer in the United States. The IBM Quantum System is to be located on Cleveland Clinic’s main campus in Cleveland.

The first quantum computer in healthcare, anticipated to be completed in early 2023, is a key part of the two organizations'10-year partnership aimed at fundamentally advancing the pace of biomedical research through high-performance computing.

Read more ...

A New AI Model can Accurately Predict Human Response to Novel Drug Compounds

The journey between identifying a potential therapeutic compound and Food and Drug Administration approval of a new drug can take well over a decade and cost upwards of a billion dollars. A research team at the CUNY Graduate Center has created an artificial intelligence model that could significantly improve the accuracy and reduce the time and cost of the drug development process.

Read more ...